Parallax Volatility Advisers, L.P. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$566,784
-30.5%
51,200
+1.8%
0.00%
-50.0%
Q2 2023$815,363
+149.8%
50,300
+156.5%
0.00%
+100.0%
Q1 2023$326,457
-53.8%
19,607
-77.7%
0.00%
Q4 2019$706,000
+24.1%
88,000
+6.5%
0.00%
Q3 2019$569,000
-26.7%
82,667
-11.6%
0.00%
Q2 2019$776,000
-60.7%
93,476
-53.0%
0.00%
-100.0%
Q1 2019$1,977,000
+262.8%
198,844
+179.2%
0.00%
Q4 2018$545,000
+141.2%
71,212
+447.8%
0.00%
Q3 2018$226,000
+804.0%
12,999
+401.3%
0.00%
Q2 2018$25,000
-24.2%
2,593
-65.3%
0.00%
Q1 2018$33,000
+10.0%
7,4740.0%0.00%
Q4 2017$30,0007,4740.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders